We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

550 hedge funds and large institutions have $9.49B invested in Varian Medical Systems, Inc. in 2017 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 166 increasing their positions, 213 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 41

77% more call options, than puts

Call options by funds: $25.4M | Put options by funds: $14.3M

13% more capital invested

Capital invested by funds: $8.4B → $9.49B (+$1.09B)

5% more funds holding

Funds holding: 522550 (+28)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

22% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 213

Holders
550
Holders Change
+28
Holders Change %
+5.36%
% of All Funds
13.71%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
73
Increased
166
Reduced
213
Closed
41
Calls
$25.4M
Puts
$14.3M
Net Calls
+$11.1M
Net Calls Change
+$27.7M
Name Holding Trade Value Shares
Change
Change in
Stake
RFS
401
Rockefeller Financial Services
New York
$393K
BTIS
402
BB&T Investment Services
North Carolina
$390K +$141K +1,463 +63%
Macquarie Group
403
Macquarie Group
Australia
$382K
JMPWA
404
JP Morgan Private Wealth Advisors
California
$380K +$15.1K +157 +4%
PCM
405
Prelude Capital Management
New York
$379K +$353K +3,669 New
CCM
406
Cadence Capital Management
Massachusetts
$371K -$6.93K -72 -2%
GT
407
Greenleaf Trust
Michigan
$371K
FM
408
Forward Management
California
$362K +$30K +311 +10%
Cambridge Investment Research Advisors
409
Cambridge Investment Research Advisors
Iowa
$361K -$11.7K -121 -3%
Thrivent Financial for Lutherans
410
Thrivent Financial for Lutherans
Minnesota
$359K +$4.82K +50 +1%
SCM
411
Sterling Capital Management
North Carolina
$354K -$101K -1,046 -23%
ACA
412
Anchor Capital Advisors
Massachusetts
$352K -$41.6M -432,156 -99%
OMCS
413
Old Mutual Customised Solutions
South Africa
$351K
WF
414
WealthTrust Fairport
Ohio
$351K
CI
415
Cigna Investments
Connecticut
$345K -$56.2K -584 -15%
BFS
416
Bradley Foster & Sargent
Connecticut
$342K +$9.82K +102 +3%
Fifth Third Bancorp
417
Fifth Third Bancorp
Ohio
$335K -$26K -270 -8%
RJFSA
418
Raymond James Financial Services Advisors
Florida
$335K +$13.6K +141 +5%
DADC
419
D.A. Davidson & Co
Montana
$327K -$20.4K -212 -6%
IB
420
Intrust Bank
Kansas
$322K +$22.5K +234 +8%
RJT
421
Raymond James Trust
Florida
$318K -$23.6K -245 -7%
BLAM
422
Bourne Lent Asset Management
New York
$315K -$19.3K -200 -6%
N
423
Nuveen
North Carolina
$313K -$392K -4,067 -57%
ZAM
424
Zevin Asset Management
Massachusetts
$310K
LCM
425
Laurion Capital Management
New York
$310K +$289K +3,000 New

VAR Hedge Fund Activity: Q2 2017 in Review

550 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q2 2017, worth a combined $9.49B — up 13% from $8.4B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new VAR positions and 41 closed out — a net gain of 32 holders — while 166 added to existing stakes and 213 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $340M. The largest seller was Generation Investment Management, exiting entirely with an estimated $227M sold.

  • 550 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q2 2017, up from 522 in Q1 2017.
  • Funds reported $9.49B of Varian Medical Systems, Inc. stock for Q2 2017, up 13% quarter-over-quarter.
  • 73 funds opened new Varian Medical Systems, Inc. positions in Q2 2017 and 41 closed out, a net change of +32 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q2 2017 was Janus Henderson Group, an estimated $340M added.
  • The largest Varian Medical Systems, Inc. seller in Q2 2017 was Generation Investment Management, an estimated $227M sold.

Based on aggregated 13F filings for Q2 2017.